2025 Annual Meeting | S14 - Neuro-ophthalmology/Neuro-otology
Program Materials Program Evaluations
11:15 AM - 11:27 AM PDT | Abstract |
001 - The Latest Data from Lenadogene Nolparvovec Gene Therapy Trials for Leber Hereditary Optic Neuropathy
Nancy J. Newman, MD, FAAN |
11:27 AM - 11:39 AM PDT | Abstract |
002 - Non-mydriatic Ocular Fundus Imaging on Consecutive Headache Patients in an Emergency Department (ED)
Kevin Yan, MD |
11:39 AM - 11:51 AM PDT | Abstract |
003 - High Frequency Vestibulo-ocular Reflex in Spinocerebellar Ataxias with Slow Saccades
Seung-Han Lee, MD, PhD |
11:51 AM - 12:03 PM PDT | Abstract |
004 - Risk of Non-arteritic Anterior Ischemic Optic Neuropathy in Patients with Type 2 Diabetes and Obesity Using GLP-1 Receptor Agonists: A Cohort Study
Filipi F. Andreão |
12:03 PM - 12:15 PM PDT | Abstract |
005 - Refining Neuro-ophthalmology Examination Proficiency in Neurology Residents Through Simulation-based Training
Abdullah Salama |
Scott Grossman, MD | Dr. Grossman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acuta Pharmaceuticals. |
Deena Tajfirouz, MD | Dr. Tajfirouz has nothing to disclose. |
Filipi F. Andreão | Mr. Andreão has nothing to disclose. |
Diogo Haddad Santos, MD | Dr. Haddad Santos has nothing to disclose. |
Dillan C. Amaral, Student | Mr. Amaral has nothing to disclose. |
Ricardo Louzada, MD, PhD | Dr. Louzada has nothing to disclose. |
Mario L. Monteiro, MD, PhD | Dr. Monteiro has nothing to disclose. |
Kevin Yan, MD | An immediate family member of Dr. Yan has received personal compensation in the range of $100,000-$499,999 for serving as a Pharmaceutical Reviewer with US Food and Drug Administration. |
George Alencastro, MD | Dr. Alencastro has nothing to disclose. |
Nithya Shanmugam, Medical Student | Ms. Shanmugam has nothing to disclose. |
Jessica McHenry | Ms. McHenry has nothing to disclose. |
Stuart J. Duffield | Mr. Duffield has nothing to disclose. |
Daniel V. Adamkiewicz, MD | Dr. Adamkiewicz has nothing to disclose. |
Duyen Vo, MD | Dr. Vo has nothing to disclose. |
Jordan Prosky | Mr. Prosky has nothing to disclose. |
Matthew Keadey, MD | Dr. Keadey has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for The Weathington Firm, LLC. |
David Wright | David Wright has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. David Wright has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astrocyte Pharmaceutical . David Wright has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for several defense legal firms. David Wright has stock in Astrocyte Pharmaceuticals. The institution of David Wright has received research support from NINDS. The institution of David Wright has received research support from Department of Defense. The institution of David Wright has received research support from Marcus Foundation. The institution of David Wright has received research support from Nico Corporation. The institution of David Wright has received research support from Center for Disease Control. David Wright has received intellectual property interests from a discovery or technology relating to health care. |
Andrew Fischer, MD | An immediate family member of Dr. Fischer has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for BrainQ Technologies. |
Mung Yan Lin, MD | Dr. Lin has nothing to disclose. |
Nancy J. Newman, MD, FAAN | Dr. Newman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GenSight. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Chiesi. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurophth. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. The institution of Dr. Newman has received research support from GenSight. The institution of Dr. Newman has received research support from Santhera. The institution of Dr. Newman has received research support from NINDS/NIH. Dr. Newman has received publishing royalties from a publication relating to health care. Dr. Newman has received publishing royalties from a publication relating to health care. Dr. Newman has received publishing royalties from a publication relating to health care. |
Valerie Biousse, MD | Dr. Biousse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gensights Biologic. Dr. Biousse has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Topcon. Dr. Biousse has received publishing royalties from a publication relating to health care. Dr. Biousse has received publishing royalties from a publication relating to health care. |
Andrew Pendley | No disclosure on file |
Michael Dattilo, MD, PhD | Dr. Dattilo has nothing to disclose. |
Seung-Han Lee, MD, PhD | Dr. Lee has nothing to disclose. |
Jae-Myung Kim, MD, PhD | Prof. Kim has nothing to disclose. |
Lakshmi Leishangthem, MD, MBBS | Dr. Leishangthem has nothing to disclose. |
Karan Tarasaria, MBBS | Dr. Tarasaria has nothing to disclose. |
Abdullah Salama | Mr. Salama has nothing to disclose. |
Patrick Yu-Wai-Man | Patrick Yu-Wai-Man has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GenSight Biologics. Patrick Yu-Wai-Man has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Chiesi. Patrick Yu-Wai-Man has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoke Therapeutics. Patrick Yu-Wai-Man has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PYC Therapeutics. |
Valerio Carelli, MD, PhD | Dr. Carelli has received personal compensation in the range of $0-$499 for serving as a Consultant for Chiesi Farmaceutici. Dr. Carelli has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Chiesi Farmaceutici. |
Magali Taiel | Magali Taiel has received personal compensation for serving as an employee of GenSight Biologics. |
Jose-Alain Sahel | The institution of Jose-Alain Sahel has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Avista. The institution of Jose-Alain Sahel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Tenpoint . The institution of Jose-Alain Sahel has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for THE BOARD OF GENSIGHT. The institution of Jose-Alain Sahel has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for THE BOARD OF SPARINGVISION. Jose-Alain Sahel has stock in Prophesee. Jose-Alain Sahel has stock in Tilak Healthcare. Jose-Alain Sahel has stock in Sparing Vision. Jose-Alain Sahel has stock in Chronolife. Jose-Alain Sahel has stock in VegaVect Inc.. Jose-Alain Sahel has stock in Avista. Jose-Alain Sahel has stock in Tenpoint. Jose-Alain Sahel has stock in SharpEye. Jose-Alain Sahel has stock in GenSight. The institution of Jose-Alain Sahel has received research support from LabEx LIFESENSES (ANR-10-LABX-65). The institution of Jose-Alain Sahel has received research support from IHU FOReSIGHT (ANR-18-IAHU-01). The institution of Jose-Alain Sahel has received research support from ERC Synergy "HELMHOLTZ". Jose-Alain Sahel has received intellectual property interests from a discovery or technology relating to health care. |